European Pharmaceutical Review

OCTOBER 20, 2022

1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to be producing them in house. Water quality from an Annex 1 and Pharma 4.0 John Wiley & Sons, Ltd, 2010. Making the journey to PAT and Pharma 4.0. The post An Annex 1 and Pharma 4.0 perspective.

Food and Drug Administration 90

Food and Drug Administration Pharma Manufacturing Food 90

World of DTC Marketing

APRIL 7, 2021

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Food and Drug Administration between 2010 and 2016 yet did taxpayers receive any discount?

Healthcare 162

Healthcare Healthcare Food and Drug Administration Pharma 162

European Pharmaceutical Review

MARCH 31, 2023

GlobalData Pharma Intelligence Center Deals Database found: SVB Financial Group and its subsidiaries were involved in more than $1.4 billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing. million in deposits.

Biopharma 92

Biopharma Pharma Networking Marketing 92

World of DTC Marketing

NOVEMBER 3, 2020

Cardiovascular disease deaths in the US have increased by nearly 17% since 2010, and are among the reasons that life expectancy in the U.S. has also seen reversals in health improvements since 2010, partly due to increasing rates of obesity, high blood pressure, and high blood sugar. . is lower than in other high-income countries.

Insurance 190

Insurance Healthcare Healthcare Physicians 190

World of DTC Marketing

MAY 2, 2021

According to data from KFF’s annual survey of employers , between 2010 and 2020, insurance premiums for employer-sponsored family coverage rose by 55 percent; the employer’s contribution went up 61 percent. How does pharma respond? The average family policy now costs over $21,000, most of which is paid by the employer.

Healthcare 277

Healthcare Healthcare Insurance Government 277

PM360

MAY 15, 2023

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

Pharma Pathway

JANUARY 12, 2023

Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. SunGlow Lifescience Pvt. Ltd-Openings for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator Dept. Job Description. SunGlow Lifescience Pvt. Our Corporate office is located in Chennai, Indian.

Manufacturing 79

Manufacturing Marketing 79

European Pharmaceutical Review

JULY 28, 2023

Soriot continued, remarking on retiring Executive Vice President of Biopharmaceuticals R&D, Mene Pangalos’ success in “delivering a greater than five-fold improvement in productivity [since 2010 and]… overseeing the creation of the DISC – our new R&D Centre in Cambridge, UK ”.

Medicine 83

Medicine Patients Pharma Pharmaceutical 83

Pharma Pathway

JANUARY 31, 2023

Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. Ltd-Walk-In Interviews for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator/ Maintenance/ Engineering/ Warehouse/ Regulatory Affairs/ QA On 5th Feb’ 2023 Job Description SunGlow Lifescience Pvt.

Engineering 86

Engineering Manufacturing Marketing Management 86

pharmaphorum

OCTOBER 1, 2022

Things have been looking bleak for the Swiss pharma group since the US Court of Appeals for the Federal Circuit (CAFC) denied its petition to rehear a case on the validity of a patent covering Gilenya (fingolimod) in relapsing-remitting MS.

Competition 52

Competition Pharma Marketing Sales 52

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. However, they can still be significantly reduced by carefully redesigning supply chains and operations without affecting health outcomes.

Government 52

Government Healthcare Healthcare Pharma 52

pharmaphorum

OCTOBER 18, 2022

Meanwhile there is an ongoing shift in the pharma industry to the use of decentralised clinical trials, where patients are asked to participate remotely, and this has led to greater use of digital, connected technologies to monitor their use of medical interventions.

Manufacturing 52

Manufacturing Pharma Marketing Medical 52

Pharma Marketing Network

APRIL 27, 2021

For more than twenty years, Susan has been a dedicated HBA volunteer serving on the global board of directors, including as President of the Global Board in 2010. The post Susan Torroella, 2020-2021 HBA STAR appeared first on Pharma Marketing Network.

Physicians 52

Physicians Networking Pharma Healthcare 52

Pharmaceutical Technology

MARCH 14, 2023

Patent volumes related to platinum-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Bristol-Myers Squibb 281 Unlock company profile F. In terms of application diversity, Synlogic is the top company, followed by Traslational Cancer Drugs Pharma and Calgent Biotechnology.

Leads 52

Leads Pharmaceutical Pharma 52

European Pharmaceutical Review

OCTOBER 2, 2023

In 2010, several companies were working on developing the method. Antibody response varies for Big Pharma COVID vaccines … Then, when the COVID-19 pandemic broke, two nucleoside base-modified mRNA vaccines encoding the SARS-CoV-2 surface protein were developed at a rapid pace, noted the Nobel Foundation.

Medicine 107

Medicine Pharmaceutical Pharma Leads 107

Medical Device Success

MARCH 13, 2011

Second and third place contenders in product categories both in medical devices and pharma tend to be lagging far behind in social media. Pfizer – 12 – One of the powerhouses of pharma is giving its competitors a lesson in social media. The last posting was in May 2010. Twitter is relevant in Medical Devices and Pharma.

Medical 100

Medical Media Pharma FDA 100

pharmaphorum

JULY 6, 2022

A new cross-sectional study has found that the FDA green lit 95% of the 89 new oncology therapies approved between 2010 and 2019 before the EMA, with the Europeans trailing the Americans by a median of 241 days. She has worked on projects for pharma, charities, and agencies, and has written extensively for patients, HCPs and the public.

Safety 88

Safety FDA Medicine Patients 88

Pharmaceutical Technology

MAY 15, 2023

Patent volumes related to nucleoside chemical synthesis Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Gilead Sciences 544 Unlock company profile Johnson & Johnson 420 Unlock company profile Merck & Co 303 Unlock company profile Illumina 238 Unlock company profile F.

Pharmaceutical 64

Pharmaceutical Leads Pharma Medicine 64

PM360

FEBRUARY 1, 2024

The Complex Launch Environment In an era marked by intense competition and a remarkable surge in prescription medication launches – experiencing a 60% growth from 2010 to 2019, per a CBO report – biopharma companies grapple with a host of challenges during product launches.

Biopharma 59

Biopharma Competition Prescription Education 59

Pharmaceutical Technology

MAY 15, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 92

Leads Biopharma Pharmaceutical Pharma 92

Pharmaceutical Technology

MAY 15, 2023

Patent volumes related to oxazole derivatives-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 8, 2023

Patent volumes related to monoclonal antibody conjugates for cancer treatment Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. By means of geographic reach, Astellas Pharma holds the top position, while TRON and Eisai stand in second and third positions, respectively.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 15, 2023

In terms of application diversity, Ascentawits Pharmaceuticals is the top company, followed by OBI Pharma and Mabwell Shanghai Bioscience. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2010, two patients with end-stage refractory chronic lymphocytic leukaemia (CLL) were administered Novartis’ autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy, Kymriah (tisagenlecleucel), as part of a Phase I trial.

Safety 111

Safety Patients Sales Manufacturing 111

pharmaphorum

NOVEMBER 18, 2022

The biotech picked up rights to teplizumab from MacroGenics in 2010, eight years after Lilly abandoned its development following a failed phase 3 trial in newly-diagnosed type 1 diabetes patients. It is now in line for a $35 million equity investment by Sanofi following FDA approval. It is anticipating a launch in the US in January.

FDA 52

FDA Patients Manufacturing Pharma 52

Pharmaceutical Technology

MARCH 14, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 72

Leads Biopharma Pharmaceutical Manufacturing 72

pharmaphorum

AUGUST 5, 2022

Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021. And of course, all of this will feed into future treatments and positive patient outcomes – the sole purpose of pharma. About the Author. References. [1]

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

Pharmaceutical Technology

MAY 8, 2023

Patent volumes related to anti-influenza antibody compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies GSK 853 Unlock company profile Johnson & Johnson 706 Unlock company profile Mitsubishi Chemical Group 391 Unlock company profile C.

Pharmaceutical 98

Pharmaceutical Leads Pharma 98

Clarify Health

JULY 13, 2020

Pharmaceutical commercialization On average, 23 approvals for new drugs were granted each year between 2000 and 2010. Bhash cautioned, “if we do not start planning for their launches today, the investment pharma is making will not pay off.” Pharma real-world data The use of real-world data emerged as an area that is ripe for progress.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Pharmaceutical Technology

MAY 15, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 52

Leads Pharmaceutical Pharma 52

Pharmaceutical Technology

MARCH 24, 2023

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.

Competition 59

Competition Marketing FDA Physicians 59

World of DTC Marketing

MAY 26, 2021

According to AbbVie’s internal data, the company collected nearly $10 billion in Humira net revenue from Medicare Part D between 2010 and 2018. Lack of Medicare Negotiation Costing Taxpayers Billions: U.S. law prohibits Medicare from negotiating directly with drug companies to lower prices. billion.

Competition 180

Competition Marketing Government Patients 180

Clarivate

MAY 24, 2022

In May 2010, the Chinese Medical Association (CMA) reached an expert consensus that defined rare diseases as those with a prevalence of less than 1 in 500,000, or with a morbidity rate of less than 1 in 10,000, among newborns. [2] Multinational pharmas seek entry for their products. Establishing a definition of rare disease.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Pharmaceutical Technology

MAY 24, 2023

Patent volumes related to tetrapeptide derivatives space Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Amgen 317 Unlock company profile Bristol-Myers Squibb 281 Unlock company profile F.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Pharmacology 52

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. This can help Pharma deliver results and respond to the customer needs faster.

Healthcare 59

Healthcare Healthcare Marketing Insurance 59

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. This can help Pharma deliver results and respond to the customer needs faster.

Healthcare 52

Healthcare Healthcare Marketing Insurance 52

Pharmaceutical Technology

MAY 15, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 52

Leads Pharmaceutical Physicians Food 52